North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations.
Publication/Presentation Date
12-24-2024
Abstract
BACKGROUND: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
OBJECTIVE: To provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.
METHODS: Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.
RESULTS: 119 expert consensus statements are provided for the management of patients with HS across these seven special patient populations.
ISSN
1097-6787
Published In/Presented At
Alhusayen, R., Dienes, S., Lam, M., Alavi, A., Alikhan, A., Aleshin, M., Bahashwan, E., Daveluy, S., Goldfarb, N., Garg, A., Gulliver, W., Jaleel, T., Kimball, A. B., Kirchhof, M. G., Kirby, J., Lenczowski, J., Lev-Tov, H., Lowes, M. A., Lara-Corrales, I., Micheletti, R., … Naik, H. B. (2024). North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations. Journal of the American Academy of Dermatology, S0190-9622(24)03395-4. Advance online publication. https://doi.org/10.1016/j.jaad.2024.11.071
Disciplines
Medicine and Health Sciences
PubMedID
39725212
Department(s)
Department of Medicine Faculty
Document Type
Article
